Vertex Pharmaceuticals Inc Balance Sheet Statement

VRTX $215.94 2.3 1.1%

13/04/21

Balanced, Large Cap, Falling Star

Market Cap £40.41bn

Enterprise Value £35.99bn

Revenue £4.52bn

Quality

Value

Momentum

StockRank™

To unlock Vertex Pharmaceuticals Inc's balance sheet statement please upgrade your membership.

	2015	2016	2017	2018	2019	2020
Period End:	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31
Period Length:	0	0	0	0	0	0
Currency:	USD	USD	USD	USD	USD	USD

Cash & Equivalents
Short Term Investments
Cash and Short Term Investments
Accounts Receivable - Trade, Net
Total Receivables, Net
Total Inventory
Prepaid Expenses
Other Current Assets, Total
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Goodwill, Net
Intangibles, Net
Long Term Investments
Note Receivable - Long Term
Other Long Term Assets, Total
Total Assets

Accounts Payable
Accrued Expenses
Notes Payable/Short Term Debt
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total
Total Current Liabilities

Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Other Liabilities, Total
Total Liabilities

Redeemable Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain (Loss)
Other Equity, Total
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.